Actively Recruiting
Healthy Lifestyles for Bipolar Disorder
Led by University of California, Berkeley · Updated on 2025-02-06
300
Participants Needed
1
Research Sites
247 weeks
Total Duration
On this page
Sponsors
U
University of California, Berkeley
Lead Sponsor
U
University College, London
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this clinical trial is to compare the effects of two different healthy lifestyles on outcomes for those with bipolar disorder. The goals are to understand the acceptability of time-restricted eating and the mediterranean diet for those who are already receiving medication treatment for bipolar disorder, and to consider how these two food plans predict changes in manic symptoms, depressive symptoms, and Quality of Life. Participants will complete daily measures of eating, sleep and mood for two weeks, and then will be assigned to follow one of the two food plans for eight weeks. The investigators will measure symptoms and Quality of Life at baseline and during and after the food plan.
CONDITIONS
Official Title
Healthy Lifestyles for Bipolar Disorder
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Meet diagnostic criteria for bipolar I or bipolar II disorder
- Have current sleep or circadian-related problems confirmed by screening
- Live in an English-speaking country with research expertise
- Speak English well and have used it for at least 10 years or demonstrate understanding
- Receiving medical care for bipolar disorder
- Mood-stabilizing medications stable for at least one month
- Have had less than 5 kg weight change in past 3 months
- Currently eat for 12 or more hours per day at least twice per week
- Able to use a camera and respond to web surveys by phone (loaner phones provided if needed)
- Not engaged in shift work or caregiving that disrupts sleep regularly
- Able to complete 7 days of dietary logs with at least 2 entries daily
- Able to complete screening and baseline questionnaires adequately
You will not qualify if you...
- Currently experiencing a depressive, hypomanic, manic, or psychotic episode
- History or treatment of eating disorders or high scores on eating disorder questionnaires
- Alcohol or substance use disorder in the past 3 months
- Active suicidal thoughts with plan, intent, or history of attempt
- Conditions interfering with participation such as pregnancy, breastfeeding, thyroid disorders, or gastrointestinal issues
- Medical conditions like HIV, AIDS, lupus, or multiple sclerosis that affect mood assessment
- Use of medications contraindicated for fasting such as clozapine or glucose-lowering drugs
- Cognitive deficits indicated by low scores on memory and concentration tests
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of California
Berkeley, California, United States, 94720
Actively Recruiting
Research Team
S
Sheri L Johnson, PhD
CONTACT
N
Nandini Rajgopal, BS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here